KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 146 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 3.32 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $938 | -25.1% | 700 | 0.0% | 0.00% | – |
| Q2 2023 | $1,253 | -54.0% | 700 | 0.0% | 0.00% | – |
| Q1 2023 | $2,723 | +14.4% | 700 | 0.0% | 0.00% | – |
| Q4 2022 | $2,380 | -40.5% | 700 | 0.0% | 0.00% | – |
| Q3 2022 | $4,000 | +33.3% | 700 | 0.0% | 0.00% | – |
| Q2 2022 | $3,000 | -40.0% | 700 | 0.0% | 0.00% | – |
| Q1 2022 | $5,000 | 0.0% | 700 | 0.0% | 0.00% | – |
| Q4 2021 | $5,000 | 0.0% | 700 | -12.5% | 0.00% | – |
| Q3 2021 | $5,000 | -37.5% | 800 | 0.0% | 0.00% | -100.0% |
| Q2 2021 | $8,000 | 0.0% | 800 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $8,000 | -11.1% | 800 | +33.3% | 0.00% | 0.0% |
| Q4 2020 | $9,000 | 0.0% | 600 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $9,000 | -18.2% | 600 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $11,000 | +10.0% | 600 | +20.0% | 0.00% | 0.0% |
| Q1 2020 | $10,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 1,773,474 | $2,376,456 | 1.12% |
| AlphaCentric Advisors LLC | 1,125,000 | $1,507,500 | 0.86% |
| Tejara Capital Ltd | 1,077,388 | $1,443,700 | 0.82% |
| Palo Alto Investors LP | 5,675,876 | $7,605,674 | 0.72% |
| Birchview Capital, LP | 571,832 | $766,255 | 0.65% |
| Altium Capital Management LP | 740,000 | $991,600 | 0.52% |
| Avidity Partners Management LP | 8,298,570 | $11,120,084 | 0.45% |
| Worth Venture Partners, LLC | 445,981 | $597,615 | 0.36% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 561,955 | $753,020 | 0.23% |
| DAFNA Capital Management LLC | 192,678 | $258,189 | 0.08% |